The secretases: enzymes with therapeutic potential in Alzheimer disease

被引:619
作者
De Strooper, Bart [1 ,2 ]
Vassar, Robert [3 ]
Golde, Todd [4 ]
机构
[1] VIB, Ctr Human Genet, B-3000 Louvain, Belgium
[2] KULeuven, B-3000 Louvain, Belgium
[3] Northwestern Univ, Dept Cell & Mol Biol, Chicago, IL 60611 USA
[4] Mayo Clin Florida, Dept Neurosci, Coll Med, Jacksonville, FL 32224 USA
关键词
AMYLOID PRECURSOR PROTEIN; GATED SODIUM-CHANNELS; NECROSIS-FACTOR-ALPHA; CELL-CELL ADHESION; GAMMA-SECRETASE; BETA-SECRETASE; KINASE-C; ASPARTYL PROTEASE; CLEAVING ENZYME; FAMILY-MEMBERS;
D O I
10.1038/nrneurol.2009.218
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The amyloid hypothesis has yielded a series of well-validated candidate drug targets with potential for the treatment of Alzheimer disease (AD). Three proteases that are involved in the processing of amyloid precursor protein-alpha-secretase, beta-secretase and gamma-secretase-are of particular interest as they are central to the generation and modulation of amyloid-beta peptide and can be targeted by small compounds in vitro and in vivo. Given that these proteases also fulfill other important biological roles, inhibiting their activity will clearly be inherently associated with mechanism-based toxicity. Carefully determining a suitable therapeutic window and optimizing the selectivity of the drug treatments towards amyloid precursor protein processing might be ways of overcoming this potential complication. Secretase inhibitors are likely to be the first small-molecule therapies aimed at AD modification that will be fully tested in the clinic. Success or failure of these first-generation AD therapies will have enormous consequences for further drug development efforts for AD and possibly other neurodegenerative conditions.
引用
收藏
页码:99 / 107
页数:9
相关论文
共 114 条
[1]   Dynamics of Aβ Turnover and Deposition in Different β-Amyloid Precursor Protein Transgenic Mouse Models Following γ-Secretase Inhibition [J].
Abramowski, Dorothee ;
Wiederhold, Karl-Heinz ;
Furrer, Ulrich ;
Jaton, Anne-Lise ;
Neuenschwander, Anton ;
Runser, Marie-Josephine ;
Danner, Simone ;
Reichwald, Julia ;
Ammaturo, Domenico ;
Staab, Dieter ;
Stoeckli, Markus ;
Rueeger, Heinrich ;
Neumann, Ulf ;
Staufenbiel, Matthias .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 327 (02) :411-424
[2]   ADAMs family members as amyloid precursor protein α-secretases [J].
Allinson, TMJ ;
Parkin, ET ;
Turner, AJ ;
Hooper, NM .
JOURNAL OF NEUROSCIENCE RESEARCH, 2003, 74 (03) :342-352
[3]   Putative function of ADAM9, ADAM10, and ADAM17 as APP α-secretase [J].
Asai, M ;
Hattori, C ;
Szabó, B ;
Sasagawa, N ;
Maruyama, K ;
Tanuma, S ;
Ishiura, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 301 (01) :231-235
[4]   Role of the APP non-amyloidogenic signaling pathway and targeting α-secretase as an alternative drug target for treatment of Alzheimer's disease [J].
Bandyopadhyay, S. ;
Goldstein, L. E. ;
Lahiri, D. K. ;
Rogers, J. T. .
CURRENT MEDICINAL CHEMISTRY, 2007, 14 (27) :2848-2864
[5]   A γ-Secretase Inhibitor Decreases Amyloid-β Production in the Central Nervous System [J].
Bateman, Randall J. ;
Siemers, Eric R. ;
Mawuenyega, Kwasi G. ;
Wen, Guolin ;
Browning, Karen R. ;
Sigurdson, Wendy C. ;
Yarasheski, Kevin E. ;
Friedrich, Stuart W. ;
DeMattos, Ronald B. ;
May, Patrick C. ;
Paul, Steven M. ;
Holtzman, David M. .
ANNALS OF NEUROLOGY, 2009, 66 (01) :48-54
[6]   A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells [J].
Black, RA ;
Rauch, CT ;
Kozlosky, CJ ;
Peschon, JJ ;
Slack, JL ;
Wolfson, MF ;
Castner, BJ ;
Stocking, KL ;
Reddy, P ;
Srinivasan, S ;
Nelson, N ;
Boiani, N ;
Schooley, KA ;
Gerhart, M ;
Davis, R ;
Fitzner, JN ;
Johnson, RS ;
Paxton, RJ ;
March, CJ ;
Cerretti, DP .
NATURE, 1997, 385 (6618) :729-733
[7]   Evidence that tumor necrosis factor α converting enzyme is involved in regulated α-secretase cleavage of the Alzheimer amyloid protein precursor [J].
Buxbaum, JD ;
Liu, KN ;
Luo, YX ;
Slack, JL ;
Stocking, KL ;
Peschon, JJ ;
Johnson, RS ;
Castner, BJ ;
Cerretti, DP ;
Black, RA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (43) :27765-27767
[8]   M1 receptors play a central role in modulating AD-like pathology in transgenic mice [J].
Caccamo, A ;
Oddo, S ;
Billings, LM ;
Green, KN ;
Martinez-Coria, H ;
Fisher, A ;
LaFerla, FM .
NEURON, 2006, 49 (05) :671-682
[9]   BACE1 is the major β-secretase for generation of Aβ peptides by neurons [J].
Cai, HB ;
Wang, YS ;
McCarthy, D ;
Wen, HJ ;
Borchelt, DR ;
Price, DL ;
Wong, PC .
NATURE NEUROSCIENCE, 2001, 4 (03) :233-234
[10]   Glu332 in the Nicastrin ectodomain is essential for γ-secretase complex maturation but not for its activity [J].
Chavez-Gutierrez, Lucia ;
Tolia, Alexandra ;
Maes, Elke ;
Li, Tong ;
Wong, Philip C. ;
de Strooper, Bart .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (29) :20096-20105